BOLD · Boundless Bio, Inc. · Executive Compensation
Market Cap
$64.38M
Shares
22.75M
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
No Compensation Data
No Summary Compensation Table has been imported from this company's proxy statements yet.
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Jessica Oien | President and "principal executive officer" | Appointed | 2026-06-23 |
| Zachary D. Hornby | member of the board of directors | Resigned | 2026-06-23 |
| Christine Brennan, Ph.D. | Board of Directors | Resigned | 2026-03-09 |
| James L. Freddo, M.D. | Interim Chief Medical Officer | Appointed | 2024-12-12 |
| Jami Rubin | Chief Financial Officer and Treasurer | Terminated | 2024-10-15 |
Key facts
CIK
1782303
CUSIP
10170A100
13F (30d)
20 filings
20 filers
Visit website
Investor relations